Resultados de la búsqueda 81-90 of 4481 for Amphotericin B
... B). Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. A Study About How Platelets Adhere to the Blood von Willebrand Factor in ...
Dao; Dra. Lori A. Erickson; Dra. Mary E. Fidler; Dr. Thomas J. Flotte; Dr. Andrew L. Folpe; Dr. Joaquin J. Garcia, presidente · Dra. Katherine B. Geiersbach ...
... B-cell hematologic malignancies including large B-cell, mantle cell and follicular lymphoma, chronic lymphocytic leukemia (CLL) and B-cell acute ...
... B). Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. Metastatic Tumor Research and Outcomes Network. Rochester, Minn. The registry ...
... B). Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. A Study to Evaluate Pembrolizumab Combined with Intensive Chemotherapy to ...
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. Aggressive Malignancy PDX (Avatar) and ...
Hussam Al Kateb, Ph.D. Rochester, MN. Sam T. Albadri, ...
... B). Mayo Clinic is only participatin gin Part B, and only in the MTR regimen. A Study to Determine How BI 907828 is Taken up in the Tumor and to ...
Jacksonville, Fla. The purposes of this study are to explore the therapeutic efficacy of BAFFR-CAR T cells in BAFFR-expressing B-cell hematologic malignancies ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?